Poseida Therapeutics, Inc. today announced that the Company’s President of Gene Therapy, Brent Warner will participate in a virtual fireside chat at the Stifel 2023 Tailoring Genes.
SAN DIEGO, May 23, 2023 /PRNewswire/ --Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that the Company's President of Gene Therapy, Brent Warner, will participate in a virtual fireside chat at the Stifel 2023 Tailoring Genes: Genetic Medicines Day on Tuesday, May 30, 2023 at 12:00pm PT | 03:00pm ET. A live webcast of the fireside chat will be available on the Investors & Media Section of Poseida's website, www.poseida.com. A replay of the webcast will be available for approximately 90 days following the presentation. About Poseida Therapeutics, Inc.
SOURCE Poseida Therapeutics, Inc. |
||
Company Codes: NASDAQ-NMS:PSTX |